# FDA recall D-0296-2022

> **Teligent Pharma, Inc.** · Class II · drug recall initiated 2021-11-30.

## Product

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

## Reason for recall

Superpotent Drug: Minimally superpotent

## Distribution

Distributed to a wholesaler in CO who further distributed Nationwide in the USA

## Key facts

- **Recall number:** D-0296-2022
- **Recalling firm:** Teligent Pharma, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2021-11-30
- **Report date:** 2022-01-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Buena, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0296-2022

## Citation

> AI Analytics. FDA recall D-0296-2022. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0296-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*